Annual Drug Patent Expirations for ZYCLARA
Zyclara is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug and two Paragraph IV challenges.
This drug has fifty-one patent family members in thirty-one countries.
The generic ingredient in ZYCLARA is imiquimod. Two suppliers are listed for this compound. Additional details are available on the imiquimod profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
